Crossmark

A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study

Crossref DOI link: https://doi.org/10.1007/s12325-021-01623-y

Published Online: 2021-02-09

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaneko, Shizuka https://orcid.org/0000-0001-6741-218X
da Rocha Fernandes, João D.

Yamamoto, Yuiko

Langer, Jakob

Faurby, Mads
Funding

Funding for this research was provided by:

Novo Nordisk A/S
License Information

Text and Data Mining valid from 2021-02-09

Version of Record valid from 2021-02-09
More Information

Article History

Received: 12 November 2020

Accepted: 12 January 2021

First Online: 9 February 2021

Document is current

Any future updates will be listed below